Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (351)	3/10/1999 5:10:00 AM
From: CPAMarty	Read Replies (1) \| Respond to of 2515

Here is an expanded version of yesterday's story messages.yahoo.com@m2.yahoo.com

To: QuietWon who wrote (351)	3/10/1999 10:31:00 AM
From: 5,17,37,5,101,...	Read Replies (2) \| Respond to of 2515

Moors&Cabot target price for IMCL is $30.00 and they rate it only a buy! I'd like to see what a strong buy is. So it broke $12.00 this AM. I thought this would happen yest aft. Watch for big sellers to come out of the woodwork (institutions?). I think they are betting that Herceptin WITH modifications may be a big competitor to C225 -- just a wild hunch. Who can explain why a drug company with major cancer drug in PIII getting lots of publicity and with partner is only selling for $12 while other willow wisp companies are selling for more? Jackson